USE OF CONSENSUS INTERFERON IN COMBINATION WITH IL-1 RECEPTOR ANTAGONIST FOR TREATMENT OF PATIENTS AFFLICTED WITH MULTIPLE SCLEROSIS

摘要

The present invention encompasses a use of a therapeutically effective amount of interferon consensus (IFN-con) in combination with an inflammatory inhibitor, such as IL-1ra, for preventing or treating multiple sclerosis in a patient. The present invention is also directed to a use of a therapeutically effective amount of IFN-con and a therapeutically effective amount of an inflammatory inhibitor, such as IL-1ra, for preparation of a medicament for preventing or treating multiple sclerosis in a patient.